Center-Authored Papers

Filters: Author is Chlebowski, Rowan T  [Clear All Filters]
Journal Article
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg C, Wactawski-Wende J, Rohan T, O'Sullivan MJ, Yasmeen S, Hiatt RA et al..  2011.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.. Maturitas. 68(1):73-8. Abstract
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S et al..  2010.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.. Journal of the National Cancer Institute. 102(18):1422-31. Abstract
Lowry SJ, Kapphahn K, Chlebowski RT, Li CI.  2016.  Alcohol use and breast cancer survival among participants in the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Neuhouser ML, Chlebowski RT, Anderson GL.  2015.  Association Between Obesity and Postmenopausal Breast Cancer Risk-Reply.. JAMA oncology. 1(8):1171.
Phipps AI, Chlebowski RT, Prentice RL, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M et al..  2011.  Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(3):454-63. Abstract
Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ et al..  2015.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.. JAMA oncology. 1(3):296-305. Abstract
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE et al..  2009.  Breast cancer after use of estrogen plus progestin in postmenopausal women.. The New England journal of medicine. 360(6):573-87. Abstract
Chlebowski RT, Anderson GL, Aragaki AK, Prentice R.  2015.  Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.. Journal of the National Cancer Institute. 108(2) Abstract
Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA et al..  2017.  Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.. Menopause (New York, N.Y.). Abstract
Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson GL, Wactawski-Wende J, Chlebowski RT.  2012.  Breast tenderness after initiation of conjugated equine estrogens and mammographic density change.. Breast cancer research and treatment. 131(3):969-979. Abstract
Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, Chlebowski RT.  2012.  Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.. Breast cancer research and treatment. 132(10):275-285. Abstract
Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, Johnson KC, O'Sullivan MJ, Jackson RD, Manson JE.  2013.  Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.. Journal of women's health (2002). 22(11):915-29. Abstract
Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, Stefanick M, Wactawski-Wende J, Carbone L, Lu B et al..  2013.  Calcium Plus Vitamin D Supplementation and Joint Symptoms in Postmenopausal Women in the Women's Health Initiative Randomized Trial.. Journal of the Academy of Nutrition and Dietetics. 113(10):1302-10. Abstract
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S et al..  2008.  Calcium plus vitamin D supplementation and the risk of breast cancer.. Journal of the National Cancer Institute. 100(22):1581-91. Abstract
Thomson CA, Horn LV, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L et al..  2014.  Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(12):2924-35. Abstract
Chlebowski RT, Pettinger M, Kooperberg C.  2012.  Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results.. The American journal of clinical nutrition. 95(1):258-9.
Chlebowski RT, Anderson GL.  2012.  Changing concepts: Menopausal hormone therapy and breast cancer.. Journal of the National Cancer Institute. 104(7):517-27. Abstract
Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC et al..  2015.  Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.. Journal of the National Cancer Institute. 107(9) Abstract
Prentice RL, Pettinger M, Beresford SAA, Wactawski-Wende J, Hubbell AF, Stefanick ML, Chlebowski RT.  2009.  Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1531-7. Abstract
Chlebowski RT, Nikolaenko L, Anderson G.  2013.  Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings.. The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. 39(3):226-8.
Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL.  2008.  Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.. Journal of the National Cancer Institute. 100(8):563-71. Abstract
McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, Wang C-Y, Johnson KC, Manson JE, Wallace RB et al..  2009.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(36):6135-43. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH et al..  2008.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
Ritenbaugh C, Stanford JL, Wu LL, Shikany JM, Schoen RE, Stefanick ML, Taylor VM, Garland C, Frank G, Lane D et al..  2008.  Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(10):2609-18. Abstract
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell AF, Lane D et al..  2012.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.. The lancet oncology. 13(5):476-486. Abstract